Mark Lebwohl

Dr. Mark Lebwohl graduated summa cum laude from Columbia College in 1974 and graduated from Harvard Medical School in 1978.  He completed residencies in internal medicine and dermatology, both at Mount Sinai. 

Dr. Lebwohl has been practicing dermatology since 1983.  He is the Waldman Professor and Chair of the Kimberly and Eric J. Waldman Department of Dermatology of the Icahn School of Medicine at Mount Sinai. Dr. Lebwohl is past President of the American Academy of Dermatology.

Dr. Lebwohl is chairman emeritus of the Medical Board of the National Psoriasis Foundation.  He is the founding editor of the NPF’s Psoriasis Forum and of the recently launched Journal of Psoriasis and Psoriatic Arthritis. He has served on the editorial board of the Journal of the American Academy of Dermatology and has served as editor of the Dermatology Section of Scientific American Medicine.  Dr. Lebwohl has chaired numerous symposia and has written, edited, or co-edited several books including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading book on dermatologic therapy, Treatment of Skin Disease. The second edition of The Skin and Systemic Disease has been published in English and in French, and English, Chinese, Portuguese, Spanish, and Polish versions of Treatment of Skin Disease have been published.  Five editions of Treatment of Skin Disease have been published, and the sixth is in development. Other books include Difficult Diagnoses in Dermatology, Psoriasis, Mild-to-Moderate Psoriasis and Moderate-to-Severe Psoriasis.  He has authored or co-authored over 500 peer-reviewed articles, and many invited articles and book chapters.  Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments. He introduced the use of imiquimod for the treatment of actinic keratosis; the use of topical calcineurin inhibitors for facial and intertriginous psoriasis; and many topical, systemic and combination therapies for psoriasis.

Featured Articles

Mindera’s SkinAtlas is a scalable platform that leverages artificial intelligence and machine learning to analyze patient-specific data collected from a dermal biomarker patch.


Mindera Newsletter

Stay ahead in the world of psoriasis treatment!

Subscribe to our newsletter and stay updated on the latest breakthroughs in biologic treatments.